Citi Sticks to Its Hold Rating for Clorox (CLX)
Citi analyst Filippo Falorni maintained a Hold rating on Clorox on February 27 and set a price target of $115.00. The company’s shares closed last Friday at $127.16.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Falorni is a 3-star analyst with an average return of 3.5% and a 64.38% success rate. Falorni covers the Consumer Defensive sector, focusing on stocks such as The Estée Lauder Companies, Newell Brands, and Clorox.
In addition to Citi, Clorox also received a Hold from Morgan Stanley’s Dara Mohsenian in a report issued on February 22. However, on February 23, Evercore ISI maintained a Sell rating on Clorox (NYSE: CLX).
Based on Clorox’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.67 billion and a net profit of $157 million. In comparison, last year the company earned a revenue of $1.69 billion and had a net profit of $193 million
Read More on CLX:
Disclaimer & DisclosureReport an Issue
- Clorox: Margin Recovery Achieved but Ambitious Growth Targets Keep Rating at Hold
- Clorox price target raised to $124 from $112 at BofA
- Clorox price target raised to $125 from $115 at Wells Fargo
- Clorox price target raised to $117 from $115 at Rothschild & Co Redburn
- Clorox Earnings Call: Innovation, ERP Wins, Margin Hopes
